Purchaser Safety Releases February Cannabis Income Details
New details contains full number of merchandise offered and common item selling price for Grownup-Use Cannabis and Healthcare Marijuana Revenue
HARTFORD — The Office of Client Protection announced these days that new preliminary facts shows combined income for grownup-use cannabis and clinical cannabis totaled additional than $18.4 million for the time period from Feb. 1, 2023, to Feb. 28, 2023, the initial full calendar month considering the fact that grownup-use profits commenced.
The adult-use current market recorded $7.02 million in gross sales throughout the thirty day period of February, whilst the professional medical cannabis marketplace recorded $11.4 million in revenue for the identical interval. February is the to start with comprehensive calendar month for which data is available. Adult-use revenue started on Jan. 10, 2023.
The info is available at ct.gov/hashish.
The Department also created obtainable new information relevant to grownup-use hashish and health care marijuana sales. The new facts demonstrates the full number of products and solutions bought in each marketplace, as effectively as the common rate for each products in each sector.
In the month of February, Professional medical Marijuana Sufferers ordered 316,644 merchandise, and grownup-use customers purchased 168,565. The DCP Drug Control Division has approved much more than 600 new model names for solutions that may be bought in equally the medical cannabis sector and the adult-use market considering that the grownup-use market place opened.
The common products cost for Clinical Marijuana sufferers was $36.11 in February, while the regular rate of adult-use goods was $41.82. This data was gathered by the state’s Seed-to-Sale Monitoring Method. DCP does not make earnings projections, set revenue anticipations, or control rates.
The facts does not incorporate taxes collected at the position of sale on grownup-use transactions, and is matter to additional overview by the division. Professional medical cannabis clients do not pay taxes on the invest in of their medication.
Gross sales information for the medical cannabis industry is not obtainable prior to Jan. 10, 2023, as seed-to-sale tracking was not formerly essential for professional medical cannabis sales. Grownup-use and medical marijuana sales are now recorded in BioTrack, the inventory monitoring procedure utilised to check the movement of hashish products in the state’s health care and adult-use hashish marketplaces.
Transaction limits of 1/4 ounce of uncooked flower or the equal remain in result for all grownup-use buys. Health care cannabis patients may possibly acquire up to 5 ounces for each month and are not matter to individual transaction boundaries.
The Division will make future info offered at ct.gov/hashish. The facts will be updated regular on or just after the 10th of each and every thirty day period, and new facts will continue on to be added as it gets to be obtainable.
Grown ups who choose to consume cannabis are reminded to do so responsibly, which includes storing cannabis goods in their unique packaging, locked up and out of achieve of little ones and pets. Sources concerning liable hashish use, as nicely as information and facts about dependancy and overall health dangers is readily available at ct.gov/cannabis.
Hashish was accepted for adult-use in June 2021. Adult-use sales began Jan. 10, 2023at certified merchants. For much more information about Grownup-Use Hashish, visit ct.gov/cannabis.
- Twitter: DCP on Twitter
- Facebook: DCP on Facebook
(860) 713-6019 (business)
(860) 377-0246 (mobile)